UCLA researchers discovered a molecule, DDL-920, that successfully restores cognitive functions in Alzheimer’s-afflicted mice by enhancing brain gamma oscillations, marking a potential breakthrough in treatment methodologies beyond the plaque removal strategies of current drugs.
UCLA researchers suggest that a compound could improve brain electrical rhythms and potentially treat schizophrenia and depression, pending human trials.
In a recent study, UCLA Health researchers identified and synthesized a molecule that successfully restored cognitive functions in mice exhibiting DOI: 10.1073/pnas.2400420121
/https://tf-cmsv2-smithsonianmag-media.s3.amazonaws.com/filer_public/d1/82/d18228f6-d319-4525-bb18-78b829f0791f/mammalevolution_web.jpg "How to Make a Mammal in Nine Evolutionary Steps")
Discussion about this post